AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ilahi, M.
Right arrow Articles by Heaney, R. P
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilahi, M.
Right arrow Articles by Heaney, R. P
Agricola
Right arrow Articles by Ilahi, M.
Right arrow Articles by Heaney, R. P
American Journal of Clinical Nutrition, Vol. 87, No. 3, 688-691, March 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Pharmacokinetics of a single, large dose of cholecalciferol1,2,3

Marium Ilahi, Laura AG Armas and Robert P Heaney

1 From the Creighton University Medical Center, Omaha, NE

Background: There is much interest in dosing vitamin D intermittently for patient convenience and long-term adherence.

Objective: The objective was to characterize the time course and response of 25-hydroxyvitamin D (calcidiol) to a large oral dose of cholecalciferol.

Design: One group (30 subjects) was supplemented with a single oral dose of 100 000 IU cholecalciferol. A second group (10 subjects) served as a control group to assess the seasonal change of calcidiol. Serum calcidiol concentrations were followed for 4 mo. The subjects were healthy with limited sun exposure (<10 h/wk) and milk consumption (<0.47 L daily). We excluded subjects with granulomatous conditions, liver disease, kidney disease, or diabetes and subjects taking anticonvulsants, barbiturates, or steroids.

Results: Serum calcidiol rose promptly after cholecalciferol dosing from a mean (±SD) baseline of 27.1 ± 7.7 ng/mL to a concentration maximum of 42.0 ± 9.1 ng/mL. Seven percent of the supplemented cohort failed to achieve 32.1 ng/mL at any time point. The highest achieved concentration in any subject was 64.2 ng/mL. The control group had a nonsignificant change from baseline of –0.72 ± 0.80 ng/mL during 4 mo.

Conclusions: Cholecalciferol (100 000 IU) is a safe, effective, and simple way to increase calcidiol concentrations. The dosing interval should be ≤2 mo to ensure continuous serum calcidiol concentrations above baseline. This trial was registered at www.clinicaltrials.gov as #NCT00473239.

Key Words: Vitamin D • cholecalciferol • 25-hydroxyvitamin D • therapeutic use • calcidiol • hydroxycholecalciferol • calcium






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition